Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Accenture
Cerilliant
Queensland Health
QuintilesIMS
Farmers Insurance
Novartis
Cipla
Dow
McKesson

Generated: January 22, 2018

DrugPatentWatch Database Preview

ISONIAZID; RIFAMPIN - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for isoniazid; rifampin and what is the scope of isoniazid; rifampin freedom to operate?

Isoniazid; rifampin
is the generic ingredient in two branded drugs marketed by Sanofi Aventis Us and Hikma Intl Pharms, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for isoniazid; rifampin. Two suppliers are listed for this compound.
Summary for ISONIAZID; RIFAMPIN
Pharmacology for ISONIAZID; RIFAMPIN

US Patents and Regulatory Information for ISONIAZID; RIFAMPIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us RIFAMATE isoniazid; rifampin CAPSULE;ORAL 061884-001 Approved Prior to Jan 1, 1982 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hikma Intl Pharms RIFAMPIN AND ISONIAZID isoniazid; rifampin CAPSULE;ORAL 065221-001 Jul 29, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Moodys
Fuji
Harvard Business School
McKinsey
Deloitte
Dow
Daiichi Sankyo
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot